Professor Pam Kearns is Chair of Clinical Paediatric Oncology at the University of Birmingham and an Honorary Consultant Paediatric Oncologist at Birmingham Women and Children’s Hospital. She is Director of the University of Birmingham’s Institute of Cancer and Genomic Sciences and Director of the Cancer Research UK Clinical Trials Unit (CRCTU). As Director of CRCTU, she leads the research strategy for one of UK’s largest cancer trials unit, delivering a trials portfolio of over 100 multi-centre & international cancer trials for a wide-range of cancers, occurring in all children, young people and adults, notably leading the National Children’s Cancer Trials Team responsible the vast majority of UK’s clinical trial portfolio for children and young people with cancer. Her research is focused on research in childhood acute leukaemias and lymphomas and drug development and innovation in the design and delivery of clinical trials for childhood cancers.
She was elected President of the European Society of Paediatric Oncology (SIOP Europe) in 2019, having been a Board member since 2013. She has several European roles including Executive Board Member of the academic consortium ‘Innovative Therapeutics in Childhood Cancer’ (ITCC), Chair of ITCC’s European Sponsor Institutions Committee and Steering Committee member of the International multi-stakeholder platform ‘ACCELERATE’. Her research interests are focused on drug development and innovation of design and delivery of clinical trials for childhood cancers. She was also a Senior Clinical Advisor to Cancer Research UK from 2015 to 2020 and is now as Trustee for Cancer Research UK as well as continuing to be a Trustee of a Child of Mine, a charity dedicated to supporting bereaved parents. She is also Chair of the Research Assessment Panel for GOSH Charity, and Chair of The Independent Scientific Advisory Panel for Bone Cancer Research Trust.